PHA 568487
CAS No. 527680-56-4
PHA 568487 ( —— )
产品货号. M24500 CAS No. 527680-56-4
奎宁环 PHA 568487 是 α7 烟碱乙酰胆碱受体的激动剂,旨在减轻与核心支架相关的生物活化,并随后消除与体内耐受性相关的负债。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥150 | 有现货 |
|
| 5MG | ¥367 | 有现货 |
|
| 10MG | ¥651 | 有现货 |
|
| 25MG | ¥1144 | 有现货 |
|
| 50MG | ¥1693 | 有现货 |
|
| 100MG | ¥2331 | 有现货 |
|
| 200MG | ¥3123 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PHA 568487
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述奎宁环 PHA 568487 是 α7 烟碱乙酰胆碱受体的激动剂,旨在减轻与核心支架相关的生物活化,并随后消除与体内耐受性相关的负债。
-
产品描述The quinuclidine PHA 568487 is an agonist of the alpha 7 nicotinic acetylcholine receptor that was designed to mitigate the bioactivation associated with the core scaffold and subsequently remove associated liabilities with in vivo tolerability.
-
体外实验PHA 568487, α-7 nAchR-specific agonist, prevents NF-κb activation in the cells.PHA 568487 treatment significantly reduces the expression of leukocyte infiltration molecules in MCAO rats and in endothelial cells after in vitro ischemia.
-
体内实验PHA 568487 treatment reduces mouse cognitive decline caused by aseptic bone fracture by promoting inflammation resolution. PHA 568487 (PHA; 0.8 mg/kg; injected intraperitoneally) reduces infarct volume and TUNEL positive neurons in the peri-infarct regions of permanent middle cerebral artery occlusion (pMCAO) and pMCAO+tibia fracture mice.The role played by a7 receptors on neuroinflammation is supported by the decrease of [18F]DPA-714 binding in ischemic rats treated with the a7 agonist PHA 568487 at day 7 after MCAO. PHA 568487-treated ischemic rats show a significant reduction of the cerebral infarct volumes and an improvement of the neurologic outcome compared with non-treated MCAO rats. Animal Model:C57BL/6J male mice (10-12 weeks old) with pMCAO Dosage:0.4 and 0.8 mg/kg Administration:Injected intraperitoneally once on day 1, or twice on days 1 and 2, after pMCAO Result:0.8 mg/kg on days 1 and 2 after pMCAO yielded the best effect on infarct volume and behavior tests.Animal Model:Adult male Sprague-Dawley rats Dosage:1.25 mg/kg Administration:Treated i.p. daily with 0.1 mL Result:Showed a significant decrease of [18F]DPA-714 binding in the ischemic cerebral hemisphere in comparison to non-treated ischemic rats.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点AChR
-
受体α7 nicotinic acetylcholine receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number527680-56-4
-
分子量288.34
-
分子式C16H20N2O3
-
纯度>98% (HPLC)
-
溶解度H2O:<40.44mg/ml (100mM); DMSO:<40.44mg/ml (100mM)
-
SMILESO=C(c(cc1)cc2c1OCCO2)N[C@@H]1C(CC2)CCN2C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shilliday F, et al. Multiple species metabolism of PHA-568487, a selective alpha 7 nicotinic acetylcholine receptor agonist. Drug Metab Lett. 2010 Aug;4(3):162-72.
产品手册
关联产品
-
Benzetimide hydrochl...
Benzetimide Hydrochloride 是毒蕈碱乙酰胆碱受体的拮抗剂。治疗抗精神病药引起的帕金森病。
-
Decamethonium bromid...
Decamethium Bromide 是一种烟碱型 AChR 部分激动剂和神经肌肉阻滞剂。
-
Dichlorisone Acetate
属于有机磷酸酯类化合物,是一种常用的环境卫生杀虫剂。
021-51111890
购物车()
sales@molnova.cn

